Glaucoma Therapeutics Market: Global Industry Analysis and Opportunity Assessment, 2017-2025

According to the latest market report published by Credence Research, Inc. “Glaucoma Therapeutics Market Size – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global Glaucoma Therapeutics  market was valued at US$ 4.42 Bn in 2016, and is expected to reach US$ 5.67 Bn by 2025, expanding at a CAGR of  2.8% from 2017 to 2025.
Market Insights
Glaucoma is chronic, degenerative disorder that damages the eye’s optic nerve that may result in vision loss and blindness. Glaucoma therapeutics is rapidly growing due to factors such as increase in prevalence of eye disorders around the world, significant unmet needs and rise in the incidence of age-related eye diseases contributing to the market growth of glaucoma therapeutics globally.
Browse the full report Glaucoma Therapeutics Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/glaucoma-therapeutics-market
For the purpose of study, global glaucoma therapeutics market is segmented on the basis of drug class such as prostaglandins analogs, beta blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors and fixed-dose combinations. It is observed that, in the base year 2016, prostaglandins analogs t was the highest contributing market segment. Prostaglandins analogs generally are given as first line therapy and higher adherence to the treatment are driving the market growth of prostaglandins analogs worldwide. Glaucoma therapeutics market is currently dominated by North America -. Factors such as higher cost of therapy and glaucoma being the second leading cause of blindness in the US are the factors driving the market growth in North America. Currently, Asia Pacific is not major revenue generating segment it is anticipated that Asia Pacific will show highest CAGR during forecast period. Factors such as increasing healthcare awareness, continuous economic development and developing healthcare infrastructure would drive the market growth during forecast period.
Market Competition Assessment:
The Glaucoma Therapeutics market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Aerie Pharmaceuticals, Akorn, Inc., Allergan plc., Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Teva Pharmaceuticals and other.
Key Market Movements:
  • Factors such as higher prevalence glaucoma disorder, increasing public awareness for treatment, improved diagnostic techniques, favorable reimbursement policies in some countries and high degree of R&D activity in development of glaucoma therapeutics are driving the market growth.
  • Due to the high unmet needs, vendors in the market are focusing on innovation and technological advances in treatment, this would further influence the market growth of glaucoma therapeutics globally.
  • However, patent expiry of major approved drugs leads to generic erosion, poor patient compliance to medication and adverse effects associated with the use of medication which would negatively impacting market growth of glaucoma therapeutics.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Post a Comment

Popular posts from this blog

Global Emu Oil Market Analysis and Forecast 2017- 2025 - Credence Research

According to a new market report published by Credence Research “ Emu Oil Market  Growth, Future Prospects and Competitive Analysis, 2016 – 2024,” the global emu oil market is expected to reach over US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Market Insights The global emu oil market is progressing at a considerable pace and is anticipated to attain significant market size over the next few years. Emu oil is manufactured using natural product from emu bird, and is widely used in various applications such as skin care, face care, hair care, medical and others. The global emu oil market was valued at US$ 94.34 Mn in 2015, and is expected to reach US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Browse the full Emu Oil Market - Market Growth, Future Prospects and Competitive Analysis, 2016 – 2024 report at  http://www.credenceresearch.com/report/emu-oil-market The market is witnessing growth due to rise in consumer awareness regardi
Read more

E-commerce Logistics Market: Global Industry Analysis and Opportunity Assessment, 2017-2025

According to a new market report published by Credence Research, Inc., “ E-commerce Logistics Market Size  (By Operational Area (International (Cross-border) and Domestic), By Service Type (Transportation, Warehousing, and Other Services), By Geography (North America, Europe, Asia Pacific, and Rest of the World)) – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025” the global e-commerce logistics market is expected to grow at a CAGR of 19.5% during the forecast period 2015 – 2025. Browse the full E-commerce Logistics Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025 report at  http://www.credenceresearch.com/report/e-commerce-market Market Insights Logistics has become an integral component of an e-commerce business as it is responsible for planning, control and flow of products from the point of origin to end-consumers. The proliferation of the e-commerce sector and consequent rise in cross-border (international) e-
Read more

Acquired Hemophilia Treatment Market Opportunities, Trends, Size And Market Share 2017 - 2025 - Credence Research

​ The latest market report published by Credence Research, Inc. “Global  Acquired Hemophilia Treatment Market  - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the acquired hemophilia treatment market was valued at USD 1,923.4 Mn in 2015, and is expected to reach USD 2,474.7 Mn by 2023, expanding at a CAGR of 3.2% from 2016 to 2023. Market Insights According to National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners suggest that, acquired hemophilia can potentially cause life-threatening bleeding complications in severe cases and in around 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known i.e. idiopathic. Browse th
Read more